Can Tests (OncotypeDX/CanAssist) Help You Avoid Chemotherapy? |
Early Breast Cancer-Dr Deepika Gupta#BreastCancer #OncotypeDX #AvoidChemo
If you’ve been diagnosed with early-stage, hormone-positive breast cancer, your doctor may recommend a test called Oncotype DX. This test can help show whether chemotherapy is likely to help you—or if it may be safely avoided.
In this video, we explain:
* What are genomic tests and why it’s done
* How the Oncotype DX score helps guide treatment decisions
* When chemotherapy may not be needed
* Treatment options if chemo is avoided, such as hormone therapy
* Why many patients can be safely treated without chemotherapy
For many people, a low or intermediate Oncotype DX score means that hormone therapy alone may be enough, helping avoid the side effects of chemotherapy while still treating the cancer effectively.
Please remember: This video is for education only. Always talk with your oncology team about what’s best for you.
Like, share, and subscribe for more patient-friendly cancer information and support
About the Doctor: Dr. Deepika Gupta – Surgical Oncologist, Sir Ganga Ram Hospital, Delhi Specialist in gastrointestinal, gynecological, breast, rectal and complex cancer surgeries.
Sir Ganga Ram Hospital, New Delhi
For Appointments: +91-9871674818
Visit: click here
#BreastCancer #OncotypeDX #AvoidChemo #EarlyBreastCancer #BreastCancerSupport #PatientEducation
#BreastCancerEducation
#HormonePositiveBreastCancer
